Department of Nuclear Medicine, The Seventh People's Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200137, P.R. China.
Department of Oncology, The Seventh People's Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200137, P.R. China.
Mol Med Rep. 2019 Mar;19(3):2431-2439. doi: 10.3892/mmr.2019.9857. Epub 2019 Jan 15.
Recently, microRNAs (miRNAs) have been acknowledged as important regulators of hepatocarcinogenesis and tumor progression. Therefore, identifying the underlying molecular mechanisms of miRNAs in the occurrence and development of hepatocellular carcinoma (HCC) may be important for understanding the pathogenesis of HCC and aid the identification of potential therapeutic strategies. In the present study, miRNA (miR)‑601 was significantly downregulated in HCC tissues and cell lines; low miR‑601 expression was strongly associated with tumor, node and metastasis staging and lymph node metastasis of patients with HCC. In addition, the overexpression of miR‑601 expression significantly inhibited the proliferation and invasion of HCC cells. Regarding the underlying mechanism, phosphoinositide‑3‑kinase regulatory subunit 3 (PIK3R3) was predicted to be a direct target of miR‑601 in HCC cells. Furthermore, restoration of PIK3R3 expression in these cells counteracted the inhibitory effects of miR‑601 on cell proliferation and invasion in HCC. Notably, miR‑601 overexpression inhibited the protein kinase B (AKT)/mammalian target of rapamycin (mTOR) signaling pathway in HCC via the regulation of PIK3R3. Collectively, these results demonstrated that miR‑601 may inhibit the progression of HCC by directly targeting PIK3R3 and regulating the AKT/mTOR signaling pathway. Therefore, miR‑601 may be an effective therapeutic target for the treatment of patients with HCC.
最近,微 RNA(miRNA)已被确认为肝癌发生和肿瘤进展的重要调控因子。因此,鉴定 miRNA 在肝细胞癌(HCC)发生和发展中的潜在分子机制,对于了解 HCC 的发病机制和辅助鉴定潜在的治疗策略可能很重要。在本研究中,miRNA(miR)-601 在 HCC 组织和细胞系中显著下调;miR-601 表达水平低与 HCC 患者的肿瘤、淋巴结和转移分期以及淋巴结转移强烈相关。此外,miR-601 表达的过表达显著抑制 HCC 细胞的增殖和侵袭。关于潜在机制,PI3K 调节亚基 3(PIK3R3)被预测为 HCC 细胞中 miR-601 的直接靶标。此外,这些细胞中 PIK3R3 表达的恢复抵消了 miR-601 对 HCC 细胞增殖和侵袭的抑制作用。值得注意的是,miR-601 过表达通过调节 PIK3R3 抑制 HCC 中的蛋白激酶 B(AKT)/雷帕霉素靶蛋白(mTOR)信号通路。综上所述,这些结果表明,miR-601 可能通过直接靶向 PIK3R3 并调节 AKT/mTOR 信号通路来抑制 HCC 的进展。因此,miR-601 可能是治疗 HCC 患者的有效治疗靶点。